We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Global PCR Market to Surpass USD 7 Billion by 2025

By LabMedica International staff writers
Posted on 03 May 2018
The global polymerase chain reaction market (PCR) was valued at USD 3.7 billion in 2017 and is projected to grow at a CAGR of 8.8% over the forecast period (2017 – 2025) to surpass USD 7.4 billion by 2025. More...
The extensive applications of the PCR laboratory technique in various fields, rising prevalence and incidence of infectious and chronic diseases, and growing need to develop advanced PCR systems for the rapid and inexpensive quantitative detection of target samples are expected to be the key growth drivers of the PCR market during the forecast period.

These are the latest findings of Coherent Market Insights (Seattle, WA, USA), a market research and consulting firm.

Based on product type, reagents and consumables hold the largest share of the PCR market due to the need to run the sample and amplify the target DNA sequence in PCR instruments. Based on end-user, academic and research laboratories account for the largest market share, on account of the increasing need for PCR systems in advanced laboratory testing and research services.

The use of PCR is increasing in the clinical diagnosis of infectious disease, nucleic acid amplification, paternity testing, DNA fingerprinting, detection and diagnosis of infectious disease, quality control, and personalized medicine. However, R&D advancements are resulting in the creation of various alternative nucleic acid amplification methods, such as loop medicated isothermal amplification, nucleic acid sequence based amplification, strand displacement amplification, and multiple displacement amplification. These methods offer better applicability and sensitivity in nucleic acid amplification, as compared to PCR, which has limitations such as contamination, sensitivity to certain classes of contaminants and inhibitors, and requirement of thermal cycling. These alternative nucleic acid amplification methods could hamper the growth of the PCR market during the forecasted period.

The key players in the PCR market offer PCR-free nucleic acid detection methods. They are also launching advanced and novel PCR instruments and consumables, which allow for rapid and easy nucleic acid amplification. Additionally, these key players have entered into a number of collaborations to expand their geographical reach and increase patient reach. Thus, the significant organic and inorganic growth strategies adopted by various key players is driving the growth of the PCR market. Geographically, there is growing demand for continuous technological advancements in PCR from the highly lucrative markets, particularly Asia Pacific, Latin America, the Middle East, and Africa.

Related Links:
Coherent Market Insights


New
Gold Member
Latex Test
SLE-Latex Test
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Host Response Immunoassay Test
MeMed BV
New
Anti-Thyroid Peroxidase Assay
LIAISON Anti-TPO
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.